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NontypeableHaemophilus influenzae (NTHi) is a frequent commensal of the humannasopharynx that causes opportunistic infection
in immunocompromised individuals. Existing evidence associates lipooligosaccharide (LOS)with disease, but the specific and relative
contributions ofNTHi LOSmodifications to virulence properties of the bacteriumhave not been comprehensively addressed.Using
NTHi strain 375, an isolate forwhich the detailed LOS structure has been determined,we compared systematically a set of isogenic
mutant strains expressing sequentially truncated LOS. The relative contributions of 2-keto-3-deoxyoctulosonic acid, the triheptose
inner core, oligosaccharide extensions onheptoses I and III, phosphorylcholine, digalactose, and sialic acid toNTHi resistance to anti-
microbial peptides (AMP), self-aggregation, biofilm formation, cultured human respiratory epithelial infection, andmurine pulmo-
nary infectionwere assessed.We show that opsX, lgtF, lpsA, lic1, and lic2A contribute to bacterial resistance toAMP; lic1 is related to
NTHi self-aggregation; lgtF, lic1, and siaB are involved in biofilmgrowth; opsX and lgtFparticipate in epithelial infection; and opsX,
lgtF, and lpsA contribute to lung infection.Depending on the phenotype, the involvement of these LOSmodifications occurs at differ-
ent extents, independently or having an additive effect in combination.Wediscuss the relative contribution of LOS epitopes toNTHi
virulence and frame a range of pathogenic traits in the context of infection.
The Gram-negative opportunistic bacterial pathogen nontype-able (noncapsulated) Haemophilus influenzae (NTHi) is a
common source of respiratory infection, is a primary causative
agent of pediatric otitis media (OM), and is frequently isolated
from adult patients suffering chronic respiratory diseases such as
chronic obstructive pulmonary disease (COPD) (1). Lipopolysac-
charide (LPS) is a major and essential component of the bacterial
cell wall that has been associated with different aspects of H. influ-
enzaepathogenicity (2–4). NTHi LPS contains no repetitive O-an-
tigen side chains found in other Gram-negative bacteria and is
referred to as lipooligosaccharide (LOS). NTHi LOS is a complex
glycolipid comprising a membrane-anchoring lipid A linked by a
single 2-keto-3-deoxyoctulosonic acid (Kdo) to a heterogeneous
oligosaccharide composed mainly of neutral heptose (Hep) and
hexose (Hex) sugars (5). Each Hep of a conserved trisaccharide
inner core backbone can be a point for the addition of a Hex or
further chain extensions, which constitute the outer core (for an
example, see Fig. 1A). The genetic blueprint for NTHi LOS bio-
synthesis is known. Examples of genes involved in LOS biosynthe-
sis that are relevant to this study include the following. opsX
encodes a heptosyltransferase adding the first L-glycero-D-
manno-heptose to Kdo (6). lgtF, lic2C, and lpsA each encode a
glycosyltransferase responsible for adding a glucose (Glc) or a ga-
lactose (Gal) as the first sugar to Hep I, II, and III, respectively
(7–9) (Fig. 1A). The lic1 operon is responsible for the synthesis
and transference of phosphorylcholine (PCho) (10). Finally, lic2A
encodes a glycosyltransferase that adds a Gal as part of a digalac-
tose epitope (11). The LOS of Haemophilus can also contain sialic
acid (5-acetylneuraminic acid [Neu5Ac]) as a terminal sugar res-
idue; siaB encodes a CMP-Neu5Ac synthetase which catalyzes the
formation of CMP-Neu5Ac, a nucleotide sugar donor used by the
sialyltransferases encoded by lic3A, lic3B, siaA, and lsgB (12–15).
The NTHi LOS molecule has been shown to participate in sev-
eral aspects of NTHi-host interplay (3, 4). Current information on
the role of LOS substitutions in NTHi infection is based on the loss
of function for defined LOS truncations independently generated
in nonisogenic genetic backgrounds. PCho can be a target for the
acute-phase C-reactive protein (CRP), which triggers comple-
ment-mediated killing through the classical pathway (16–18), can
correlate with increased outer membrane integrity and decreased
binding of antibodies to LPS (19), and can contribute to NTHi
resistance to the antimicrobial peptide (AMP) LL-37/hCAP18
(20). PCho also influences growth of NTHi as a biofilm (21–23),
can facilitate bacterial interaction with the human respiratory ep-
ithelium (24), and can blunt the mouse pulmonary clearance of
NTHi clinical isolates (25). The digalactose moiety confers resis-
tance to killing by complement (17), and expression of two digal-
actosides may enhance H. influenzae virulence (26). Sialylated
LOS glycoforms promote resistance to serum killing (14, 27) and
play a role in formation of biofilms by NTHi (28–30). Despite the
available evidence, there has not been any systematic phenotypic
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study on panels of isogenic mutants generated on a pathogenic
strain to further our understanding of the specific and the relative
roles of particular LOS structures in NTHi virulence. Based on this
notion, we took advantage of NTHi strain 375 (hereafter referred
to as NTHi 375), an isolate for which the detailed LOS structure
has been determined (14, 31), to generate mutants defective for a
range of LOS-specific enzymes, evaluate the effect of sequential
LOS truncation on a range of virulence phenotypes, and assign
specific roles in pathogenic properties to distinct moieties of the
LOS. We considered the roles of Kdo, the triheptose inner core,
oligosaccharide extensions on Hep I and III, PCho, digalactose,
and sialic acid. We evaluated bacterial resistance to AMPs, self-
aggregation and biofilm formation, infection of human respira-
tory epithelial cells (including bacterial adhesion, invasion, and
cell inflammatory response), and persistence and clearance in a
murine pulmonary model. This work provides a context for the
relative importance of NTHi LOS moieties to a range of virulence
traits, providing a greater understanding of LOS contribution to
NTHi pathogenesis.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. Strains used in this
study are described in Table 1. NTHi strains were grown (overnight at
37°C and 5% CO2) on chocolate agar plates (bioMérieux) or on brain
heart infusion (BHI) agar plates supplemented with 10 g/ml of hemin
and 10 g/ml of NAD, referred to as sBHI, and also with erythromycin at
10 g/ml (Erm10) or kanamycin at 11 g/ml (Km11), when required.
Escherichia coliwas grown on Luria-Bertani (LB) broth or LB agar plates at
37°C, supplemented with either ampicillin at 100 g/ml (Amp100) or
erythromycin at 150 g/ml (Erm150), when necessary.
NTHi 375 is an OM isolate (14, 31); NTHi 375 lic1 has been de-
scribed previously (32). Genes hap (NTHi0354), siaB (HI1279), siaT
(HI0147), lic2A (HI550), lgtF (HI653), lpsA (HI765), and opsX (HI261),
and their respective adjacent regions, were amplified by PCR with Taq
polymerase (Promega) using NTH i375 genomic DNA as the template
and primers hap-F1/hap-R1, siaB-F1/siaB-R1, siaT-F1/siaT-R1, lic2A-F1/
lic2A-R1, lgtF-F1/lgtF-R1, lpsA-F1/lpsA-R1, and opsX-F1/opsX-R1, re-
spectively. Primers were designed based on the genome sequences of H.
influenzae strains Rd KW20 and NTHi 86-028NP (33, 34) (see Table S1 in
the supplemental material). The gene-containing fragments were sepa-
rately cloned into pGEM-T Easy (Promega), generating pGEMT/hap,
pGEMT/siaB, pGEMT/siaT, pGEMT/lic2A, pGEMT/lgtF, pGEMT/lpsA,
and pGEMT/opsX. Cloned PCR products were disrupted by inverse PCR
with Vent polymerase (New England BioLabs), using primers hap-F2/
hap-R2, siaB-F2/siaB-R2, siaT-F2/siaT-R2, lic2A-F2/lic2A-R2, lgtF-F2/
lgtF-R2, lpsA-F2/lpsA-R2, and opsX-F2/opsX-R2, respectively (see Table
S1). In all cases, an internal 30-bp fragment was replaced by a blunt-
ended (excised by SmaI) erythromycin resistance cassette from pBSLerm
(35), generating plasmids pALG-1, pPMO-7, pSM-1, pPMO-8, pPMO-9,
pPMO-10, and pPMO-11 (Table 1). These plasmids were digested with
NotI to obtain linear disruption cassettes for hap, siaB, siaT, lic2A, lgtF,
lpsA, and opsX that were used to transform NTHi 375 using the MIV
method (36). Transformants were screened by plating bacteria on sBHI
agar plates containing Erm10. The NTHi 375 lgtF lpsA mutant was
generated by two successive recombination events. First, strain NTHi 375
lgtF was generated as described above, and then it was transformed with
a disruption cassette for lpsA. This disruption cassette was generated by
cloning a blunt-ended kanamycin resistance cassette released from
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FIG 1 (A) LOS structure proposed for NTHi 375. Genes of interest, disrupted in this work, are indicated in gray, with white empty arrows indicating their point
of action. (B) Electrophoretic profiles following SDS-PAGE of LOS isolated from the NTHi 375 wild type andlpsA,lgtFlpsA,lgtF,siaB,lic2A, andopsX
mutants. A pair of profiles, before () and after () neuraminidase treatment, is shown for each strain. (C) Detection of PCho epitope by colony immunoblot-
ting on wild-type NTHi 375 (WT) and lic1, lic1ABCD-c, siaB, lic2A, lgtF, and lpsA mutants. GlcN, glucosamine; PEtn, phosphoethanolamine; Hep,
heptose; Glc, glucose; Gal, galactose; PCho, phosphorylcholine; OAc, O-acetyl; P, phosphate.
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pUC4K by digestion with HincII in a vector obtained by inverse PCR of
pGEM-T/lpsA with primers lpsA-F2/lpsA-R2. The resulting plasmid,
pPMO-12, was digested with NotI, creating a 3.8-kb linear fragment
which contains the disruption cassette lpsA::Kmr, used to transform NTHi
375lgtF. Double-recombination events were selected on sBHi agar con-
taining Erm10 and Km11.
Complementation of NTHi 375 lgtF, lic2A, and lic1 strains was
carried out by inserting the relevant gene into open reading frame (ORF)
HI0601.1; this ORF contains a frameshift in H. influenzae Rd KW20 (37).
Copies of lgtF, lic2A, and lic1ABCD genes were used to complement the
NTHi 375lgtF,lic2A, andlic1 mutants, respectively. PCR was used to
amplify a 2.3-kb fragment from NTHi 375 genomic DNA using primers
HI0601.1-F1/HI0601.1-R1. This fragment was cloned into pGEM-T Easy
and sequenced, confirming that HI0601.1 in NTHi 375 also contained a
frameshift. HI0601.1 was disrupted by inverse PCR with Vent polymerase
using primers HI0601.1-F2/HI0601.1-R2. An internal 30-bp fragment
was replaced by a kanamycin resistance cassette from pUC4K, generating
pPMO-4. Genes lgtF, lic2A, and lic1ABCD, with their respective promoter
regions, were amplified with Vent polymerase from NTHi 375 genomic
DNA using primers lgtF-prF1/lgtF-stopR1, lic2A-prF1/lic2A-stop, and
lic1-prF1/lic1-stopR1, respectively. These fragments were phosphory-
lated and ligated into a vector generated by inverse PCR of pPMO-4 with
primers HI0601.1-R2/pUC4K-R1, creating pPMO-13, pPMO-14, and
pPMO-15, respectively (Table 1). These plasmids were digested with
NotI, generating DNA fragments of 3.9, 4.5, and 7.1 kb, used to transform
NTHi 375 lgtF, lic2A, and lic1 strains, respectively. Complemented
strains were selected on sBHi agar containing Erm10 and Km11.
Preparation and neuraminidase treatment of LPS. Bacterial lysates
were prepared from cells grown overnight on BHI plates supple-
mented with Levinthal’s reagent (10%) and neuraminic acid (Neu5Ac;
Boehringer Ingelheim) (50 g/ml) and adjusted in phosphate-buff-
ered saline (PBS) to an optical density at 260 nm (OD260) of 1. Ten-
microliter suspensions were lysed by boiling for 5 min. The lysates
were treated (37°C overnight) with 2.5 l of neuraminidase (4 U/l)
from Clostridium perfringens (Boehringer Ingelheim) and subse-
quently boiled for 5 min.
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Description Reference or source
H. influenzae
375 Wild type 31
375 lic1 lic1BC::ermC Ermr 32
375 siaB siaB::ermC Ermr This study
375 lic2A lic2A::ermC Ermr This study
375 lgtF lgtF::ermC Ermr This study
375 lpsA lpsA::ermC Ermr This study
375 lgtF lpsA lgtF::ermC lpsA::km Ermr Kmr This study
375 opsX opsX::ermC Ermr This study
375 lic1ABCD-c lic1BC::ermC Hi0601.1::km::lic1ABCD Ermr Kmr This study
375 lic2A-c lic2A::ermC Hi0601.1::km::lic2A Ermr Kmr This study
375 lgtF-c lgtF::ermC Hi0601.1::km::lgtF Ermr Kmr This study
375 siaT siaT::ermC Ermr This study
375 hap hap::ermC Ermr This study
E. coli
CC118 Used for cloning and aggregation assays
Plasmids
pGEM-T Easy Used for cloning assays Promega
pGEM-T/HI0601.1 Pseudogene HI0601.1 and flanking regions cloned into pGEM-T Easy This study
pPMO-4 Derivative of pGEM-T/HI0601.1 Disruption of HI0601.1 from NTHi375 with a Kmr cassette This study
pGEM-T/siaB siaB from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/lic2A lic2A from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/lgtF lgtF from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/lpsA lpsA from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/opsX opsX from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/siaT siaT from NTHi 375 and flanking regions cloned into pGEM-T Easy This study
pGEM-T/hap hap from NTHi 375 (nucleotides 2028–4230) cloned into pGEM-T Easy This study
pBSLerm Source of an Ermr cassette 35
pUC4K Source of a Kmr cassette Addgene
pPMO-7 pGEM-T/siaB derivative where siaB is disrupted by an Ermr cassette This study
pPMO-8 pGEM-T/lic2A derivative where lic2A is disrupted by an Ermr cassette This study
pPMO-9 pGEM-T/lgtF derivative where lgtF is disrupted by an Ermr cassette This study
pPMO-10 pGEM-T/lpsA derivative where lpsA is disrupted by an Ermr cassette This study
pPMO-11 pGEM-T/opsX derivative where opsX is disrupted by an Ermr cassette This study
pPMO-12 pGEM-T/lpsA derivative where lpsA is disrupted by a Kmr cassette This study
pPMO-13 pMO-4 derivative where Pr::lgtF is cloned into pPMO-4, generating a disruption of HI0601.1 This study
pPMO-14 pPMO-4 derivative where Pr::lic2A is cloned into pMO-4, generating a disruption of HI0601.1 This study
pPMO-15 pPMO-4 derivative where Pr::lic1ABCD is cloned into pMO-4, generating a disruption of HI0601.1 This study
pSM-1 pGEM-T/siaT derivative where siaT is disrupted by an Ermr cassette This study
pALG-1 pGEM-T/hap derivative where hap is disrupted by an Ermr cassette This study
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LPS electrophoretic separation. The patterns of LPS isolated from
wild-type and mutant strains of H. influenzae, before and after neuramin-
idase treatment, were determined after fractionation by tricine-SDS-poly-
acrylamide gel electrophoresis (T-SDS-PAGE) (38) using 17.7% gels and
silver staining (Quicksilver; Amersham, United Kingdom) according to
the manufacturer’s instructions. Gels were scanned and images were re-
corded for densitometry analysis using ImageJ software; bands in each
lane were analyzed, and lane profile plots were generated.
Colony immunoblotting.An assessment of PCho levels on the surface
of NTHi strains was carried out by colony immunoblotting using
TEPC-15 antibody (Sigma), as previously described (39).
Antimicrobial peptide susceptibility assay. The antimicrobial pep-
tide susceptibility assay was adapted from reference 40. Bacteria were
grown on 10 ml of sBHI to the exponential growth phase (OD650  0.3)
and then harvested by centrifugation at 3,500  g for 20 min at 20°C.
Bacteria were washed once with PBS, and a suspension containing 105
CFU/ml was prepared in 10 mM PBS (pH 6.5), 1% tryptone soy broth
(TSB; Oxoid), and 100 mM NaCl. Aliquots of 5l of this suspension were
mixed in microcentrifuge tubes with various concentrations of polymyxin
B (PxB) or human  defensin-1 (hBD-1) (prepared in 10 mM PBS [pH
6.5], 1% TSB, and 100 mM NaCl). In all cases, the final volume was 30l.
After 60 min of incubation at 37°C, surviving bacteria were enumerated
following culture on sBHI agar. Results are expressed as the ratio of the
number of bacteria surviving compared to the number of bacteria in a
control lacking antimicrobial peptide (AMP), expressed as a percentage.
The 50% inhibitory concentration (IC50) of PxB was defined as the con-
centration producing a 50% reduction in the colony counts compared to
those of bacteria not exposed to the antibacterial agent. According to
guidelines of the NIH Chemical Genomics Center, the IC50 of a given drug
was determined from a dose-response curve data fit using a standard
four-parameter logistic nonlinear regression analysis. Dose-response ex-
periments were performed in duplicate, on at least four independent oc-
casions (n 8).
Bacterial aggregation assay. Three or four colonies of NTHi or E. coli
grown on chocolate agar or LB plates, respectively, were inoculated into
20 ml of sBHI (NTHi) or LB (E. coli) medium, grown overnight, diluted in
the same medium to an OD600 of 1, and left standing at room temperature
for 7 h (starting volume,20 ml). The viability of each culture was tested
by serial dilution and plating on sBHI agar or LB agar. OD600 readings
were performed at regular intervals on 500-l aliquots collected from the
top of each bacterial suspension. At least four independent experiments
(n 4) were performed for each strain.
Biofilm formation. Biofilm formation under flow conditions was as-
sessed using 60-ml microfermentors (Pasteur Institute, Laboratory of Fer-
mentation) with a continuous flow of medium (40 ml/h) and constant
aeration with sterile compressed air (30,000 Pa). Submerged Pyrex glass
slides served as the growth substratum. Three or four colonies of each
strain grown on chocolate agar plates were inoculated in 20 ml of sBHI
medium and incubated with shaking up to an OD600 of 1. Approximately
108 bacteria from this culture were used to inoculate the microfermentor,
which was then run at 37°C for 16 h. The viability of each inoculated
bacterial aliquot was tested by serial dilution and plating on sBHI agar.
Biofilm development was recorded with a Nikon Coolpix 950 digital cam-
era. To quantify the biofilm formed, bacteria adhered to the Pyrex slides
were resuspended in 10 ml of PBS. The OD600 of the suspensions was
determined. Experiments were performed on at least three independent
occasions (n 3).
Epithelial cell culture and bacterial infection. Carcinomic human
alveolar basal epithelial cells (A549, ATCC CCL-185) were maintained as
described before (41). Cells were seeded at 6  104 cells/well in 24-well
tissue culture plates for 32 h and serum starved 16 h before infection,
reaching 90% cellular confluence at the time of infection. For NTHi in-
fection, bacteria were recovered with 1 ml of PBS from a chocolate agar
plate grown for 16 h. The bacterial suspension was adjusted to an OD600 of
1 in PBS (109 CFU/ml). A549 cells were infected in 1 ml of Earle’s
balanced salt solution (EBSS; Gibco) to get a multiplicity of infection of
100:1. For adhesion experiments, cells were infected for 30 min, washed
5 times with PBS, and lysed with 300 l of PBS-saponin (0.025%) for 10
min at room temperature, and serial dilutions were plated on sBHI agar.
For invasion assays, cells were infected for 2 h, washed 3 times with PBS,
and incubated for 1 h with RPMI 1640 containing 10% fetal calf serum
(FCS), HEPES, and gentamicin (200 g/ml) to kill extracellular bacteria.
Cells were washed 3 times with PBS and lysed as described before. In all
cases, infection experiments were carried out in triplicate and on at least
three independent occasions (n 9).
Secretion of IL-8. A549 cells were maintained and infected for 2 h, as
described above. Cells were washed 3 times with PBS and incubated with
fresh medium containing gentamicin (100g/ml) for 6 or 20 h. Superna-
tants were removed from the wells, cell debris was removed by centrifu-
gation, and samples were frozen at 80°C. Interleukin 8 (IL-8) levels in
the supernatants were measured using an enzyme-linked immunosorbent
assay (ELISA) kit (Innova). Infection experiments were carried out in
duplicate and on at least two independent occasions (n 4).
Mouse assays. CD1 female mice (4 to 5 weeks old) were purchased
from Charles River Laboratories and housed under pathogen-free condi-
tions at the Institute of Agrobiotechnology facilities (registration number
ES/31-2016-000002-CR-SU-US). For NTHi infection, bacteria were re-
covered with 1 ml of PBS from a chocolate agar plate grown for 16 h, to
obtain a suspension of 5  109 CFU/ml. Before infection, mice were
anesthetized by intraperitoneal inoculation of a mixture of ketamine-
xylazine (3:1). Each mouse received 20 l of inoculum (108 CFU) in-
tranasally. Groups of 5 mice were euthanized and necropsied at selected
intervals, to obtain samples from upper airways, tracheas, and lungs for
histopathological studies and/or to determine the number of CFU per
lung.
Histopathology and lesion score. Heads, tracheas, and lower respira-
tory tracts with lungs from mice infected with NTHi 375 were aseptically
removed, at 24 and 48 h postinfection (p.i.), during necropsy. Animals
receiving 20 l of PBS intranasally were used as controls. Heads were
immersed in 10% neutral buffered formalin and maintained for 2 days,
rinsed in running tap water for 2 h, and decalcified with 5% nitric acid for
24 to 36 h. After complete fixation and decalcification, 5 transaxial slices
were made every 3 to 4 mm beginning at the nostrils and finishing in the
nasopharynx. Tracheas and lungs were fixed overnight in 10% buffered
formalin and embedded in paraffin, and 4- to 6-m sections were stained
with hematoxylin and eosin (H&E) by standard procedures and examined
by microscopy to determine the presence and extent of inflammation and
lesions. Lesions in the airways and lungs were subjectively scored on a
scale of 0 to 3 (0, absent; 1, mild; 2, moderate; and 3, severe) depending on
the percentage of tissue affected, the epithelial changes, the degree of in-
flammatory cell infiltration, and the degree and type of exudates in lu-
mens. Similar sections were stained for immunohistochemistry (IHC).
Sections were subjected to antigen retrieval by heating the slides in a
pressure cooker for 3 min in distilled water pH 4.0. IHC staining was
performed using an EnVision horseradish peroxidase (HRP) kit (Dako
Corporation, USA) and a polyclonal rabbit anti-NTHi antibody (41). For
tissue controls, similar organs obtained from noninfected mice were pro-
cessed in a manner identical to that for the infected tissues. For a serum
control, similar sections of tissues obtained from infected mice were pro-
cessed using a conventional rabbit serum. The images were observed and
digitalized using an Olympus Vanox AHBS3 microscope coupled to an
Olympus DP12 digital camera.
Lung bacterial counting.Mice (n 5) were infected intranasally with
wild-type or mutant strains. Lungs were aseptically removed, individually
weighed in sterile bags (Stomacher 80; Seward Medical), homogenized,
and serially 10-fold diluted in PBS. Each dilution was spread on sBHI agar
plates to determine the number of viable bacteria (detection limit 	 10
CFU/lung). The individual number of CFU/lung was logarithmically
transformed for data normalization and graphically represented by box
plot using the StatViewGraphics 5.0 for Windows (SAS Institute Inc.)
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statistical package. Box whiskers represent 99% of data; lines inside boxes
represent median values.
Statistical analysis. For AMP resistance, self-aggregation, biofilm
growth, epithelial cell infection, and IL-8 secretion assays, means
 stan-
dard deviations (SDs) were calculated, and statistical comparison of
means were performed using the two-tailed t test. In mouse experiments,
statistical comparisons of mean log10 CFU/lung were performed by a one-
way analysis of variance (ANOVA) followed by the Fisher’s protected least
significant difference (PLSD) tests. In all cases, a P value of 	0.05 was
considered statistically significant. Analyses were performed using the
Prisma4 for PC (GraphPad Software) or StatViewGraphics 5.0 for Win-
dows (SAS Institute Inc.) statistical package.
RESULTS
Construction and characterization of sequential LOS trunca-
tions on NTHi 375. We constructed a set of mutant strains ex-
pressing sequentially truncated LOS molecules in NTHi 375; this
isolate has been used for previous studies on NTHi biology and
infection (14, 32, 41), and its LOS structure has been determined
(Fig. 1A). We generated NTHi 375 siaB, lic2A, lgtF, lpsA,
lgtF lpsA, and opsX mutant strains. Table 1 lists all strains
used in this work. The profiles of LOS purified from wild-type and
mutant strains were analyzed by tricine-SDS-PAGE and staining
with silver, following neuraminidase treatment to assess the pres-
ence of sialic acid. LOS from NTHi 375lgtF,lic2A,lpsA,lgtF
lpsA, and opsX mutants showed a stepwise decrease in molec-
ular weight (Fig. 1B; see also Fig. S1A in the supplemental mate-
rial). Neuraminidase treatment resulted in the appearance of a
lower band in the LOS profile from the wild-type and lgtF
strains, corresponding to a loss of Neu5Ac from sialylated glyco-
forms, and in removal of the lowest band in LOS from the lic2A
mutant strain (Fig. 1B; see also Fig. S1B). The presence of PCho
was assessed on the panel of mutant strains by colony immuno-
blotting using mouse anti-PCho antibody TEPC-15. Wild-type,
siaB, lic2A, lgtF, and lpsA strains showed reactivity to
TEPC-15, while thelic1 (32, 41),lgtFlpsA, andopsX strains
did not (Fig. 1C and data not shown). Complementation of the
lic1 mutation (NTHi 375 lic1ABCD-c strain) restored a PCho
signal comparable to that observed with the wild-type strain (Fig.
1C). The NTHi 375 lgtF mutant displayed a PCho signal similar
to that of the wild-type strain, suggesting that on NTHi 375, some
PCho could be linked to the Glc attached to Hep III in the absence
of the Glc added by LgtF. None of the mutants exhibited growth
defects compared to the wild-type when grown in liquid culture
(data not shown).
LOS truncation increases susceptibility to soluble elements
of innate immunity. Antimicrobial peptides (AMPs) play an im-
portant role in host protection against infections, and pathogens
have developed strategies to counteract their antimicrobial action
(42–45). We evaluated the contribution of LOS moieties on NTHi
375 to resistance to AMP-mediated killing. First, we studied the
survival of the wild-type and mutant strains in the presence of
increasing doses of PxB. PxB is an experimental substitute for
AMPs, commonly used to demonstrate AMP resistance in labora-
tory settings because of a similar mechanism of action against
Gram-negative bacteria (46, 47). The results are shown in Table 2
and in Fig. S2 in the supplemental material. NTHi 375 lic1 was
more susceptible to PxB than the wild-type strain, supporting pre-
vious observations with different AMPs (20). The lic1ABCD-c
complemented strain restored this deficiency. NTHi 375 siaB
showed no significant change in resistance to PxB compared to the
wild-type strain. This observation was supported by NTHi 375
siaT, a mutant strain deficient in sialic acid uptake. The lic2A
and lpsA mutants showed a slight increase in susceptibility to
PxB, which may be due to the absence of digalactose in each case.
Resistance was restored to a wild-type level in the lic2A-c com-
plemented strain. NTHi 375 lgtF displayed lower resistance to
PxB than did the wild-type strain, suggesting that the addition of
Glc on Hep I or its substitution with PCho contribute to bacterial
resistance to AMPs. Strains NTHi 375 lgtF lpsA and opsX
were the most susceptible ones, suggesting a correlation between
increasing LOS truncation and higher sensitivity. Data obtained
for NTHi 375 lgtF lpsA, compared to those of lgtF and lpsA
mutants, suggest that the two LOS substitutions play nonredun-
dant roles on NTHi resistance to PxB.
Similar findings were obtained when the susceptibility of the
strains to hBD-1, a natural AMP found in the airway (48), was
assessed (Table 2).
Together, these results suggest contributions for the triheptose
inner core, sugar extensions on Hep I and III, PCho, and digalac-
TABLE 2 NTHi LOS sequential mutant strains resistance to polymyxin B- and human -defensin 1 (g/ml)-mediated killing after bacterial
incubation with the AMP
Strain name
or genotype
% survivala at indicated concn(g/ml) of:
Polymyxin B
hBD-1, 0.51 0.75 0.5 0.25 0.125
NTHi 375 5.6
 4 13.7
 8.5 92.1
 11.4 99.7
 9.7 101.1
 10.9 90.3
 8.4
lic1 2.2
 1 11.9
 3.6 30.9
 4.7b 91.3
 4.9 92.1
 2.9 52.6
 19.1b
lic1ABCD-c 5.9
 2.8 13.9
 6.6 87.5
 15.9 102.5
 20.1 97.4
 4.8 87.5
 14.6
siaB 5.7
 8 14.2
 19.7 98.1
 11.7 121.1
 10.4 111.8
 12.5 85.2
 10.5
lic2A 1.9
 2.4b 4.8
 2.5b 69.6
 4.1b 93
 5.2 102.1
 5 74
 8.3b
lic2A-c 5.2
 3.5 8.6
 4.3 93.9
 2.8 108.4
 4 100
 3.2 102.1
 9.4
lgtF 3.5
 5.5 8.7
 7.5 53.5
 9.3b 67.7
 8b 95.8
 7.4 57.2
 7.4b
lgtF-c 6.1
 4.2 9.9
 3.3 96
 5.4 101.3
 5.2 107.8
 6 101.2
 2.8
lpsA 1.3
 1.5b 2.8
 2.5b 72.6
 8.2b 92.1
 6.5 97.1
 11.7 78.5
 5.5b
lgtF lpsA 0b 0.1
 0.1b 24.6
 4.5b 78.2
 6.2b 92.7
 1.8 35.4
 7b
opsX 0b 0b 3.2
 3.8b 9.5
 10b 13.4
 7.3b 28.9
 10.9b
a Expressed as percentage of survival of untreated bacteria (considered as 100%).
b P	 0.05 versus parental NTHi 375 tested at each given concentration.
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tose to NTHi resistance to AMP-mediated killing. A correlation
between serial LOS truncation and AMP sensitivity could be es-
tablished for PxB and hBD-1.
Heterogeneous effect of LOS truncation on self-aggregation
and biofilm formation. NTHi undergoes self-aggregation, which
may promote microcolony formation on host cell surfaces (49). To
investigate the contribution of LOS structure to NTHi forming ag-
gregates, we performed tube-settling assays with the panel of NTHi
375 mutant strains. The optical density of bacterial suspensions was
monitored over time and compared to that of control strains E. coli
CC118, which remained stable in suspension over time, and NTHi
375 hap, a mutant displaying less self-aggregation than the wild-
type strain (Table 3). NTHi 375 wild-type, siaB, lic2A, lgtF,
lpsA, lgtF lpsA, and opsX strains presented comparable aggre-
gation profiles. NTHi 375 lic1 aggregated faster than the other
strains, which reverted to wild-type levels with the complemented
lic1ABCD-c strain (Table 3; see also Fig. S3 in the supplemental
material). These results suggest that under the conditions tested,
PCho plays some role in NTHi self-aggregation.
Studies indicate that NTHi can form biofilm communities (4).
We investigated the contribution of LOS epitopes to the forma-
tion of biofilm communities for NTHi 375 grown under contin-
uous-flow culture conditions in microfermentors (50). We mon-
itored biofilm development in microfermentors by measuring the
turbidity of bacterial suspensions detached from removable glass
slides (Fig. 2). Strains NTHi 375 lic1 and lgtF (P 	 0.005), as
well as the siaB and lgtF lpsA (P 	 0.0005) mutants, were
significantly impaired in biofilm formation compared to the wild-
type strain. This deficiency was restored to a wild-type level for the
complemented strains NTHi 375 lic1ABCD-c and lgtF-c.
NTHi 375 lgtF showed reduced biofilm formation, despite the
presence of PCho and sialic acid in its LOS molecule, suggesting
that the Glc on Hep I, or PCho linked to that residue, may play a
prominent role in biofilm growth. NTHi 375 lgtF lpsA formed
biofilms similar to those formed by the lgtF single mutant.
Strains NTHi 375 lic2A, lpsA, and opsX formed biofilms not
significantly different from those formed by the wild-type strain.
In sum, the results obtained show that PCho, sialic acid, and
sugar extension on Hep I influence the capacity of NTHi to de-
velop biofilm communities.
LOSsugar extensiononHep I is important toNTHi infection
of epithelial cells, and the inner core modulates inflammation.
The interplay of NTHi with the human respiratory epithelium
plays a determinant role in the progression of the infection (51).
We infected A549 cells, a model human type II pneumocyte cell
line which NTHi 375 is known to adhere to and invade (41, 52), to
assess the role of LOS in NTHi-host cell interplay. Adhesion of
NTHi 375 lgtF, lgtFlpsA, and opsX was lower than that dis-
played by the wild-type strain (Fig. 3A). Following on from this
observation, the same mutants invaded A549 cells significantly
less than the wild-type strain. Complementation of the lgtF muta-
tion restored invasion to wild-type levels (Fig. 3B). Intracellular
bacteria were found to colocalize with a fluid marker of acidic
subcellular compartments (Lysotracker) in all cases (data not
shown), as shown before for the wild-type strain (41).
TABLE 3 Self-aggregation (decrease of absorbance at 600 nm) of NTHi mutant strains expressing truncated LOS with time
Strain name
or genotype
Decrease of absorbance at 600 nm at:
1 h 1.5 h 2 h 3 h 4 h 5 h 6 h
E. coli CC118 1.03 1.03 1.04 1.03 1.04 1.03 1.03
NTHi 375 0.98
 0.1 0.71
 0.1 0.53
 0.1 0.28
 0.1 0.17
 0.1 0.11 0.08
hap 1.03
 0.02 0.95
 0.03 0.84
 0.06 0.69
 0.1 0.56
 0.06 0.47
 0.04 0.36
 0.06
lic1 0.58
 0.1a 0.36
 0.1a 0.22a 0.07a 0.05a 0.03a 0.02a
lic1ABCD-c 0.91
 0.1 0.69
 0.2 0.5
 0.2 0.22
 0.1 0.14
 0.1 0.08 0.06
siaB 1.04
 0.1 0.78
 0.1 0.6
 0.2 0.29
 0.1 0.18
 0.1 0.12
 0.1 0.08
lic2A 0.99
 0.1 0.68
 0.2 0.44
 0.2 0.19
 0.1 0.1 0.08 0.06
lgtF 0.96
 0.1 0.75
 0.2 0.58
 0.2 0.32
 0.2 0.21
 0.1 0.16
 0.1 0.11
lpsA 0.92
 0.2 0.6 0.35 0.18 0.1 0.06 0.05
lgtF lpsA 0.99
 0.1 0.64
 0.1 0.34
 0.1 0.15 0.08 0.07 0.04
opsX 1.01 0.85
 0.1 0.61
 0.1 0.28
 0.1 0.17 0.12 0.08
a OD600 values for NTHi 375 lic1 were significantly lower (P	 0.0001 at 1 to 1.5 h; P	 0.05 from 2 h to the end of the assay) than those obtained for the wild-type strain.
∆siaB NTHi375 ∆lic1ABCD-c ∆opsX ∆lic1 
Strain OD600nm of bacterial suspension 
 
detached from glass slide 
NTHi375 1.79±0.29 
lic1 0.99±0.48a 
lic1ABCD-c 1.58±0.07 
siaB 0.93±0.22b 
lic2A 1.48±0.14 
lgtF 0.91±0.45a 
lgtF-c 1.57±0.16 
lpsA 1.71±0.3 
lgtF lpsA 1.08±0.35b 
opsX 1.83±0.11 
FIG 2 Effect of LOS truncation on NTHi 375 biofilm formation under con-
tinuous-flow conditions, in microfermentors containing the glass slides where
bacteria formed the biofilm. Images are from a representative experiment for
wild-type NTHi 375 and lic1, lic1ABCD-c, siaB, and opsX mutants. The
bottom panel shows the OD600 of bacterial suspension detached from glass
slide for each strain. Data shown are means and SDs of absorbance values,
compared by a two-tailed t test, versus those obtained for NTHi 375. aP 	
0.005; bP	 0.0005.
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We and others have shown previously that NTHi infection
triggers the secretion of proinflammatory cytokines by epithelial
cells (53). We sought to determine the impact of LOS structure on
IL-8 secretion by A549 cells. lic1, siaB, lic2A, lgtF, lpsA,
andlgtFlpsA strains induced levels of IL-8 at 6 and 20 h postin-
fection similar to those induced by the wild-type strain. In con-
trast, infection with strain NTHi 375 opsX stimulated the secre-
tion of IL-8 to levels significantly higher than those triggered by
the wild-type strain, at 6 and 20 h postinfection (Fig. 3C).
These data suggest that some LOS structure, such as the Hex on
Hep I, may be important for NTHi infection of epithelial cells and
that loss of all core structure impairs bacterial invasion and en-
hances the cell inflammatory response.
Contribution of LOS moieties to NTHi375 mouse pulmo-
nary infection. NTHi persistence on a mouse infection model has
been previously assessed by intratracheal or intranasal inoculation
of pathogenic strains and mutant derivatives, or of mutant deriv-
atives of the nonpathogenic strain H. influenzae Rd KW20 (25,
54–57). To assess the relative roles of LOS moieties in NTHi per-
sistence and/or clearance within mice, we carried out intranasal
infection of CD1 mice with NTHi 375 wild-type and mutant
strains. NTHi 375 was used to establish infection dose, adequate
intervals of study, and histopathological changes of respiratory
tissues in the mouse model. Histopathological analysis of upper
airways, trachea, and lungs from mice infected intranasally with
NTHi 375 was performed by both H&E and IHC staining and
compared with tissues from vehicle (PBS)-inoculated mice. The
sections were examined blind as sets by a trained veterinary pa-
thologist (M. Barberán). The microscopy score of the average le-
sion in samples of mice infected with NTHi 375 is shown in the
bottom portion of Fig. 4. In the upper airways, the most severe
lesions were observed at 24 h postinfection (p.i.), whereas in tra-
chea and lungs, the lesions peaked at 48 h p.i. Lungs and airways
from control mice instilled with PBS did not show either signifi-
cant inflammation or pathological changes. By H&E, the upper
airways showed some subepithelial and intravascular neutrophils
and sloughed lining epithelial necrotic cells at 24 h p.i. (Fig. 4U1
and -U2). The lumens of the turbinates were filled with seropuru-
lent exudate and detached epithelial cells. Immunostained NTHi
antigen was located in the cytoplasm of some phagocytic cells
present in the luminal exudate (Fig. 4U3). The most intense tra-
cheal lesions were found in mice sacrificed at 48 h p.i., with a
greater quantity of cellular exudate in the lumen (Fig. 4T1 and
-T2). Immunostained NTHi antigen was located in phagocytic
cells present in luminal exudates (Fig. 4T3). The most severe pul-
monary histopathological lesions were also observed in mice eu-
thanatized at 48 h p.i., showing large areas of acute bronchopneu-
monia (Fig. 4L1 and -L2). In these areas, alveolar septa were
thickened and edematous and had an inflammatory infiltrate,
mainly neutrophils and hyperplasic type 2 pneumonocytes. Alve-
olar spaces were filled with neutrophils, phagocytic mononu-
cleated cells, and small alveolar hemorrhages. Suppurative bron-
chitis and bronchiolitis with neutrophilic subepithelial infiltrates
and seropurulent exudates in the lumens were also observed.
NTHi antigen was found in the cytoplasm of cells in the pneu-
monic areas (Fig. 4L3). These pathogenic findings in lungs corre-
lated to bacterial loads of 5.13 
 0.65 and 3.15 
 0.48 log CFU/
lung (means
 SDs) at 24 h and 48 h p.i., respectively (Fig. 5).
For the purpose of strain comparison, we quantified bacterial
loads for each mutant from lung homogenates of infected mice at
24 and 48 h p.i. We recovered significantly fewer NTHi 375 lgtF
lpsA (24 h p.i., P 	 0.05; 48 h p.i., P 	 0.01) and opsX (P 	
0.001) bacteria than bacteria of the parental strain at times (Fig. 5).
NTHi 375 lgtF rendered significantly fewer bacteria than the
wild-type strain at 24 h p.i. (P	 0.05). NTHi 375 siaB delivered
counts indistinguishable from those obtained after infection with
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FIG 3 Infection of A549 epithelial cells by NTHi strains with serial LOS trun-
cation. (A) Effect of LOS truncation on NTHi epithelial adhesion. Wild-type
NTHi 375 and lic1, siaB, lic2A, lgtF, lpsA, lgtF lpsA, and opsX
mutants were used to infect cells for 30 min. The number of bacteria adhered/
well is shown for each strain. Mean numbers were significantly lower (*, P	
0.05) than those obtained for the wild-type strain for the lgtF, lgtF lpsA,
and opsX mutants. (B) Effect of LOS truncation on NTHi epithelial cell
invasion. Wild-type NTHi 375 andlic1,siaB,lic2A,lgtF,lgtF-c,lpsA,
lgtF lpsA, and opsX mutants were used to infect cells for 2 h. The number
of invading bacteria/well is shown for each strain. Mean numbers were signif-
icantly lower (*, P	 0.0001) than those obtained for the wild-type strain for
the lgtF, lgtF lpsA, and opsX mutants. (C) Effect of LOS truncation on
NTHi-mediated inflammatory response. IL-8 secreted to the supernatant by
cells upon infection with wild-type NTHi 375 and the lic1, lic2A, siaB,
lgtF,lpsA,lgtFlpsA, andopsX mutants was quantified at 6 (white bars)
and 20 (gray bars) h postinfection by ELISA. CON, noninfected cells. Mean
numbers for the opsX mutant were significantly (*, P 	 0.001) higher than
those obtained for the wild-type strain at 6 and 20 h postinfection.
Morey et al.
4106 iai.asm.org Infection and Immunity
 o
n
 January 24, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
the wild-type strain. NTHi 375 lic1, lic2A, and lpsA strains
showed a slight but not significant reduction in the number of
bacteria recovered, compared to the wild-type strain. Given that
mutations causing the most severe LOS truncations caused a faster
bacterial clearance from the lungs of infected mice than that
shown by the wild-type strain, data indicate that LOS decoration is
likely to delay the clearance of NTHi in mice pulmonary infec-
tions.
DISCUSSION
This study delineates novel roles for LOS moieties in a number of
properties related to the pathogenesis of NTHi. Our in-depth
comparison of serially truncated LOS in mutants in a strain back-
ground whose LOS structure had been previously determined has
systematically established for the first time correlations between
specific LOS moieties and a range of characteristics underlying
pathogenic traits. Previous studies have explored LOS phenotypes
in groups of NTHi mutants. The abilities of NTHi 2019 siaB,
siaA, andlsgBmutants to form biofilms have been compared in
vitro (28) and in vivo (29); the persistence of NTHi 2019licD and
siaB mutants in mouse lungs has been assessed (25, 56), and the
interference of LOS biosynthetic gene inactivation on Hap outer
membrane location has been tested in H. influenzae Rd KW20
(58). Also, high-throughput insertion tracking by deep sequenc-
ing (HITS) showed the importance of LOS structure for H. influ-
enzae Rd KW20 survival in the mouse lung (54). None of these
studies utilized mutant strain panels expressing serial LOS trun-
cation in a pathogenic strain background. In this study, we used
NTHi 375, an isolate that naturally lacks any sugar extension on
Hep II given that it lacks the lic2C gene, focusing the study on
sugar extensions on Hep I and III (Fig. 1A). The frequency of lic2C
distribution among strains is variable, depending on the strain set
(8, 59). We generated a series of mutants that express serial LOS
truncations and then assessed their effect on a number of traits
relating to bacterial interplay with the host. A summary of the
results obtained is shown in Fig. 6. Our results indicate that PCho
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FIG 4 Histopathological findings and lesion scores in the respiratory system of CD1 mice intranasally infected with NTHi 375. (Top) Tissue sections were H&E
stained and lesions subjectively scored on a scale from 0 to 3 (0, absent; 1, mild; 2, moderate; and 3, severe) for inflammatory markers. Selected tissue sections were
also IHC stained to detect NTHi 375 antigen in the lesions. The left column shows upper airways from an infected mouse analyzed at 24 h p.i. (U1) Mild epithelial
degeneration and necrosis and small amounts of luminal exudate (H&E). (U2) Detail of the lumen of the turbinate filled with serous exudate, neutrophils, and
detached epithelial cells (H&E). (U3) NTHi antigen located in the cytoplasm of neutrophils in the luminal exudate (IHC). The middle column shows the trachea
from an infected mouse sacrificed at 48 h p.i. (T1) Seropurulent exudate in the tracheal lumen (H&E). (T2) Detail of the exudate from T1 (H&E). (T3)
Immunostained NTHi antigen located in the cytoplasm of large phagocytic cells present in the luminal exudate (IHC). The right column shows a lung from an
infected mouse analyzed at 48 h p.i. (L1) Large areas of acute bronchopneumonia. (L2) Detail of alveolar spaces and thickened alveolar septa filled with
neutrophils and macrophages. (L3) NTHi antigen in the cytoplasm of some phagocytic cells (IHC). (Bottom) Histopathological average lesion scores obtained
from sections of upper airways (left), tracheas (middle), and lungs (right) at 24, 48, and 72 h p.i. In the upper airways, the most severe lesions were observed at
24 h p.i., whereas in trachea and lungs, the lesions peaked at 48 h p.i.
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not only is important for protecting NTHi against LL-37/hCAP18
(20) but also protects from PxB and hBD-1 and supports its role in
biofilm formation (21, 23, 25, 60). NTHi 375 lic1 was the only
mutant tested presenting a significant increase in self-aggregation,
maybe related to the favored exposure of molecules important for
this bacterial property. NTHi 375 displays PCho on a Glc on Hep
I; given that NTHi 375 lgtF, lacking such a Glc on Hep I, ren-
dered a positive signal for PCho, this modification is likely to
locate on Hep III in this mutant. Therefore, we speculate that
properties displayed by NTHi 375 lgtF could relate to the ab-
sence of a sugar extension on Hep I and/or the presence of PCho
on a Hex on Hep III, which could be due to some activity for
Lic1D, allowing it to have some dual functionality depending
upon the array of glycoforms presented as the template during
LPS synthesis. In any case, we demonstrate a previously unknown
involvement of Glc on Hep I in bacterial resistance to PxB and
hBD-1, in biofilm growth, and in epithelial infection. Intratra-
cheal injection of NTHi 2019 and 86-028NP wild-type and licD
mutant derivatives into mice showed that this mutant exhibited a
modest strain-specific attenuation at 24 h p.i., more consistent at
48 h p.i. (25, 61). Separately, intranasal infection of mice with an
H. influenzae Rd KW20 transposon insertion mutant library
showed that the lic1D gene was nonessential in the lungs (54). In
that study, the mouse pulmonary infection model used rendered a
mild, nonsignificant involvement of PCho in bacterial persistence
in the lung. Conversely, NTHi 375 lgtF clearance from lung ho-
mogenates was higher than that of the wild-type strain, mainly at
24 h p.i. A minor role for lgtF in NTHi survival in the lung has been
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suggested by HITS (54), and this is the first time a defined NTHi
lgtF mutant has been tested in vivo.
The digalactose moiety confers resistance to serum killing (17).
In this study, it also appears to play some role in resistance to
killing by AMPs. Conversely, sialic acid, known to play a role in
bacterial resistance to serum (14), did not seem to influence NTHi
resistance to AMPs. Our data confirmed the previously identified
role of sialic acid in biofilm growth (28–30). Moreover, NTHi 375
lic2A and siaB mutants did not display significant defects in
bacterial persistence in the mouse lung. A role for sialic acid in
NTHi survival in the lung had been previously excluded by mice
intratracheal injection of NTHi 2019 wild-type and siaB mutant
strains (56). However, Neu5Ac substitution of LOS seems to play
a key role in experimental OM (31). Strain NTHi 375siaB retains
the ability to take up sialic acid from the host (a functional sialic
acid uptake system is conserved) but cannot activate the sugar,
thereby abrogating all Neu5Ac incorporation into LOS glyco-
forms.
We also show a further phenotype for sugar extension on Hep
III of LOS, previously involved in NTHi resistance to serum killing
(8). NTHi 375lpsA was less resistant to killing by AMPs PxB and
hBD-1, indicating a role for the sugar extension on Hep III, which
includes the digalactose, in this process. Interestingly, NTHi 375
lpsA formed a biofilm indistinguishable from that of the wild-
type strain, an unexpected result given that this mutant lacks sialic
acid. We speculate that truncation of the sugar extension on Hep
III allows other structures in the LOS important for biofilm
growth to be more prominently exposed, compensating for the
absence of sialic acid. Of note, it has been reported that NTHi 2019
pgmB, a mutant expressing LOS truncated at the triheptose core,
forms a biofilm (28). Simultaneous mutation of lgtF and lpsA in
NTHi 375 suggests a synergy for extensions on Hep I and III on
bacterial resistance to AMPs and on survival in the lung. Biofilm
growth and NTHi interaction with epithelial cells were similar for
NTHi 375 lgtF lpsA and lgtF strains, suggesting a dominant
effect of sugar extension on Hep I on those virulence traits.
The most truncated mutant, NTHi 375 opsX, lacking all core
sugars and exposing the Kdo attached to lipid A, showed a signif-
icant defect in bacterial resistance to AMPs. Serial LOS truncation
may alter the hydrophobic properties of the bacterial cell surface,
such that removal of particular epitopes, or combinations of
them, may result in a significantly more hydrophobic surface en-
vironment. As reported for other pathogens, a stepwise elevation
in the surface hydrophobicity on shorter LOS chains could make
the microbe more susceptible to AMPs (62). TheopsX mutation
also restricted bacterial epithelial invasion, but it still enabled a
robust biofilm to be formed. LPSs from other bacteria have also
been shown to influence biofilm production. For example, the
absence of the outer core on Campylobacter jejuni LOS enhances
biofilm formation (63). These data support a model in which the
cell envelope is dynamic, with compensatory changes in response
to truncation or elimination of others, likely selected for under
certain cultural and environmental conditions. Indeed, LOS ex-
pression seems to be altered during NTHi growth as a biofilm
compared to planktonic growth (64), evidence obtained through
reactivity of the LPS monoclonal antibody (MAb) 6E4, which
binds to an inner core LPS epitope that includes the Kdo structure
(65). Given that NTHi 375 opsX formed a robust biofilm, and
that MAb 6E4 rendered a significant signal on biofilm grown bac-
terial extracts (64), data support a positive role for Kdo on the
NTHi biofilm interface. NTHi 375 opsX also induced an en-
hanced proinflammatory response upon epithelial cell infection.
O antigen has been proposed to mediate evasion from early epi-
thelial innate immune activation by delaying LPS recognition for
other pathogens (66). NTHi 375 opsX was severely attenuated
for infecting the lung, in agreement with HITS data (54). We spec-
ulate that this impairment could be related to enhanced suscepti-
bilities to AMPs and serum, together with stimulation of an effec-
tive proinflammatory response.
The phase variation of LOS epitopes exerted through nucleo-
tide repeats situated within biosynthetic genes is important for H.
influenzae-host interplay and pathogenesis. For example, the dy-
namics of H. influenzae LOS expression following exposure to
human serum have been recently examined by sequencing the 5=
end of LOS-related phase-variable genes from bacteria that have
evaded complement-mediated killing. This revealed a shift from a
phase-off to a phase-on status in several phase-variable genes, and
incorporation of the respective epitopes into LOS could account
for the observed evasion of complement (67). In this study, we
have systematically assessed a range of virulence related pheno-
types in mutant strains expressing serially truncated LOS, with an
aim to establish gene-to-function relationships. Most of these mu-
tants express LOS of reduced complexity and correspondingly in-
corporate fewer phase-variable epitopes compared to those of the
wild-type strain. However, some potential effect of phase varia-
tion of LOS epitopes on those phenotypes cannot be excluded and
would be of interest to investigate in future studies.
The phenotypic screening performed also allowed framing of
these traits in the context of infection. The most truncated mu-
tants, NTHi 375 opsX and lgtF lpsA, displayed a significant
impairment in their ability to interact with AMPs and epithelial
cells and to infect mice. Conversely, these mutants did not display
differences in self-aggregation, compared to the wild-type strain,
and the former strain formed a robust biofilm. NTHi 375 lic1
and lic2A displayed an increased sensitivity to AMPs, and NTHi
375lic1 andsiaB displayed an impaired ability to form biofilm;
however, these mutants did not show significant defects in lung
survival. The results obtained for NTHi 375 lgtF, lpsA, and
lgtF lpsA suggest that Glc extension on Hep I and III may have
additive effects on bacterial resistance to AMPs but that extension
on Hep I may have a dominant role on bacterial biofilm growth
and epithelial interplay. Regarding lung infection, the reduced
initial infection of NTHi 375 lgtF lpsA could be attributable to
a defect in the Hep I branch (i.e., lgtF), even though data ob-
tained at 48 h p.i. suggest that sugar extensions from Hep I and III
may play nonredundant roles on NTHi lung survival. Altogether,
this study further reinforces the importance of LOS molecule on
NTHi pathogenicity, uncovers novel gene-function associations
for LOS moieties, and supports the notion that NTHi-host inter-
play is a complex multifactorial process influenced by numerous
features of both the bacterium and the host.
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